Center for Immunotherapy and Cell-Based Technologies
Novosibirsk — Kaliningrad — Moscow — IrkutskData For Adipose Stem Cell Heart Attack Trial Published In JACC
Cytori Therapeutics (NASDAQ: CYTX) has announced the publication of previously reported six-month outcomes from APOLLO, the Company's European clinical trial evaluating adipose-derived stem and regenerative cells (ADRCs) in patients with acute myocardial infarction (heart attack or AMI), as Research Correspondence in the Journal of the American College of Cardiology...
Cell-based technologies for medicine
Stem cells are able to migrate into tissue lesions and differentiate there into those cells which are required for effective tissue regeneration. As a matter of fact, stem cell-based technologies enable to replace the complicated surgery on organ transplantation by the cell grafting, an ambulatory procedure with an equivalent potential.
